Neo Ivy Capital Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$333
-99.9%
2,568
-46.0%
0.22%
-33.0%
Q1 2022$372,000
-8.1%
4,752
+5.7%
0.34%
-42.2%
Q4 2021$405,000
+289.4%
4,496
+502.7%
0.58%
+453.3%
Q3 2020$104,000
-85.0%
746
-83.7%
0.10%
-59.9%
Q2 2020$694,000
+298.9%
4,565
+156.0%
0.26%
-7.4%
Q1 2020$174,000
-74.9%
1,783
-60.9%
0.28%
-27.6%
Q2 2019$694,0004,5650.39%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders